FDA Approves 'Bionic Eye' for Retinitis Pigmentosa Patients
The device uses a combination of electrodes in the retinal that receive wireless transmissions from a specialized video camera mounted on a pair of glasses to enable adults who have lost most or all of their vision to detect light and dark in the environment.
Clinical studies reviewed by the FDA showed the device helped otherwise blind subjects perform simple tasks such as matching gray-toned socks or detecting street curbs, with 19 of 30 subjects experiencing no adverse side effects. However, 11 participants experienced serious side effects including erosion of the conjunctiva, retinal detachment and hypotony, according to the report.
More Articles on Medical Devices:FDA Issues Device Quality Concern Notice to Hospira
Dr. D. Kevin Lester Performs First US Knee Replacements With NavioPFS
Hamilton Medical Issues Alert for Anesthesia Ventilator Software Problems
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- Innovation in GI: Advances in gastroenterology technology & technique
- A game changer for GI — Dr. Anthony Starpoli on how the TIF procedure can control regurgitation
- How to create a strategic partnership with a hospital
- 9 states with the highest & lowest physician salaries
- Frenetic consolidation: The anesthesia market today & where ASCs fit in